IDH3A and glioma: One of the most central genetic characteristics is the isocitrate dehydrogenase mutation (IDH1) status that is commonly expressed in low-grade gliomas and reflects a favorable prognosis relative to IDH1 wild-type gliomas that are high-grade glioblastomas [3,4].